Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.12.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.12.2024 | 454 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 02.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.12.2024ISIN NameCA81012R1064 SCOTTIE... ► Artikel lesen | |
02.12.24 | Astorg Completes Take Private of Hamilton Thorne and Concurrent Acquisition of Cook Medical Reproductive Health | 388 | Business Wire | Establishing a Global Leader in Assisted Reproductive Technology Consumables and Equipment
Hamilton Thorne delists from the Toronto Stock Exchange Cook Medical Reproductive Health ("Cook... ► Artikel lesen | |
29.11.24 | Hamilton Thorne Ltd.: Hamilton Thorne Announces Closing of Going Private Transaction | 677 | Newsfile | Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - November 29, 2024) - Hamilton Thorne Ltd (TSX: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments... ► Artikel lesen | |
14.11.24 | Hamilton Thorne Ltd.: Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2024 | 289 | Newsfile | Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables,... ► Artikel lesen | |
HAMILTON THORNE Aktie jetzt für 0€ handeln | |||||
17.10.24 | Hamilton Thorne Ltd.: Hamilton Thorne Provides Update on Going Private Transaction | 394 | Newsfile | Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - October 17, 2024) - Hamilton Thorne Ltd (TSX: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments,... ► Artikel lesen | |
17.09.24 | Hamilton Thorne Ltd.: Hamilton Thorne Announces Shareholder Approval of Going Private Transaction | 602 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd (TSX: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
UNITEDHEALTH | 257,40 | +0,10 % | Bitcoin überholt Google! Folgt Apple als Nächstes? AMD, UnitedHealth im Check | Der Bitcoin sorgt wieder einmal für Furore, die Kryptowährung erreichte ein neues Allzeithoch. Samir Boyardan und Andreas Wolf von HeavytraderZ analysieren die Gründe und zeigen, wie es jetzt weitergeht.... ► Artikel lesen | |
MEDTRONIC | 80,12 | +0,16 % | Ihre wichtigsten Termine: Home Depot, DocMorris, Medtronic, Stratec, Baywa und Alcon legen Zahlen vor! | © Foto: Fabian Sommer/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 06:55... ► Artikel lesen | |
INTUITIVE SURGICAL | 412,95 | +0,17 % | ISRG's International Push for Ion: Strategic Bet or Overstretch? | ||
TELADOC HEALTH | 6,150 | -0,68 % | 780 % Rendite dank teurer Medizin: PanGenomic Health, CVS Health, Teladoc Health | Die Kosten im Gesundheitswesen explodieren. Wie KFF, eine führende gesundheitspolitische Organisation der USA schreibt, gaben die Vereinigten Staaten bereits 2022 rund 4,5 Billionen USD für Gesundheit... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,118 | +0,85 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
SYNLAB | 12,710 | 0,00 % | Synlab Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update | -- Increased Net Sales and Improved Loss from Operations in Q2 2025 vs. Prior Year Quarter --
-- Evofem Advances Plans for Special Meeting of Stockholders to Approve... ► Artikel lesen | |
HCA HEALTHCARE | 350,90 | -0,31 % | HCA Healthcare stock price target raised to $417 from $404 at Bernstein | ||
LANTHEUS | 48,310 | +0,25 % | Pre-market Movers: Myriad Genetics, LifeMD, Evolus, Lantheus Holdings, Astera Labs | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.15 A.M. ET).In the Green Myriad Genetics, Inc. (MYGN) is up over 30% at $5.04.
Astera... ► Artikel lesen | |
ENVISTA | 17,400 | 0,00 % | Envista Holdings Corporation: Envista Reports Second Quarter 2025 Results | BREA, Calif., July 31, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended June 27, 2025.
"Envista achieved... ► Artikel lesen | |
CAREDX | 10,380 | -0,67 % | CareDx stock price target lowered to $22 at BTIG on Medicare reimbursement concerns | ||
GT BIOPHARMA | 1,080 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2025 Financial Results | GTB-3650 TriKE® Phase 1 trial has successfully completed Cohort 1 and Cohort 2 dosing, treating a total of four patients; following Cohort 2's formal safety review, it has advanced into Cohort 3 and... ► Artikel lesen | |
SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Preliminary Fourth Quarter and Fiscal Year 2025 Results | Expects Record Fiscal Year Revenue, Net Income, Adjusted EBITDA and Cash Flow
HENDERSON, Nev., Aug. 19, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:... ► Artikel lesen | |
CARMAT | 0,416 | -2,58 % | XFRA CXT: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCARMAT EO -,04 CXT... ► Artikel lesen | |
CHEMOMETEC | 68,95 | -1,15 % | Chemometec A/S: Preliminary revenue figures for the 2024/25 financial year | ANNOUNCEMENT NO. 290 1 July 2025 Preliminary revenue figures for the 2024/25 financial year Based on the preliminary financial figures, ChemoMetec now expects revenue of around DKK 496 million... ► Artikel lesen |